STAT+: Alnylam’s heart drug troubles take center stage at a cardiology conference
The European Society of Cardiology Congress that kicks off Friday in Munich will be a consequential meeting for Alnylam Pharmaceuticals.
We haven't written up this one. STAT News has the full story — the link below goes straight to it.